DarioHealth Corp Financial Ratios

DarioHealth Corp -- USA Stock  

USD 2.07  0.09  4.55%

We urge you to utilize analysis of DarioHealth Corp fundamentals to see if markets are presently mispricing the company. We found thirty-four available fundamental indicators for DarioHealth Corp which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all DarioHealth Corp fundamentals including its Price to Sales, Cash Flow from Operations, Current Liabilities, as well as the relationship between Cash and Equivalents and Market Capitalization . Please also check DarioHealth Corp Number of Shares Shorted to verify the company can sustain itself down the road.Use DarioHealth Corp to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of DarioHealth Corp to be traded at $2.59 in 30 days

DarioHealth Corp Company Summary

DarioHealth Corp competes with Edwards Lifesciences, Digirad, and . Its flagship product is Dario Smart Diabetes Management Solution a mobile realtime cloudbased diabetes management solution based on a multifeature software application combined with Dario Smart Meter a pocketsized blood glucose monitoring device. LabStyle Innovations Corp is also pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement as well as various general methods of rapid tests of body fluids using mobile devices and cloudbased services. LabStyle Innovations Corporation was founded in 2011 and is headquartered in Caesarea Israel.

DarioHealth Corp Current Ratio vs Net Income

DarioHealth Corp is rated # 2 in current ratio category among related companies. It is rated # 3 in net income category among related companies .

DarioHealth Corp Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare DarioHealth Corp to competition
FundamentalsDarioHealth CorpPeer Average
Return On Equity(116.23) % (15.17) %
Return On Asset(115.09) % (15.64) %
Profit Margin(140.68) % (5.5) %
Operating Margin(386.17) % (10.91) %
Current Valuation13.81 M152.14 B
Shares Outstanding10.4 M1.43 B
Shares Owned by Insiders41.61 % 6.91 %
Shares Owned by Institutions2.04 % 18.37 %
Number of Shares Shorted146.5 K3.24 M
Price to Earning(2.34) times40.69 times
Price to Book4.49 times14.44 times
Price to Sales5.08 times17.81 times
Revenue3.78 M9.85 B
Gross Profit(1000 K)21.75 B
EBITDA(14.31 M)1.41 B
Net Income(5.59 M)517.71 M
Cash and Equivalents4.14 M3.89 B
Cash per Share0.43 times5.17 times
Debt to Equity(4.21) % 0.72 %
Current Ratio2.11 times3.3 times
Book Value Per Share0.41 times13.64 times
Cash Flow from Operations(10.41 M)1.25 B
Short Ratio4.73 times2.09 times
Earnings Per Share(0.79) times2.3 times
Number of Employees1910.67 K
Beta-0.840.34
Market Capitalization19.24 M29.78 B
Total Asset5.08 M126.86 B
Retained Earnings(43.35 M)38.24 B
Working Capital2.6 M3.58 B
Current Asset4.29 M36.8 B
Current Liabilities1.69 M33.34 B
Z Score-17.8708.73
< 81% 

Chance of Financial Distress

DarioHealth Corp has more than 81 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Compare

Compare DarioHealth Corp To Peers
Erez Raphael Chairman, CEO and Pres
Zvi BenDavid CFO, Treasurer, Secretary
More Executives

Opportunity Range

October 20, 2017 Opportunity Range